Pinnacle Financial Partners Inc raised its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 243,140 shares of the healthcare conglomerate’s stock after purchasing an additional 13,794 shares during the quarter. UnitedHealth Group accounts for about 2.9% of Pinnacle Financial Partners Inc’s portfolio, making the stock its 6th biggest position. Pinnacle Financial Partners Inc’s holdings in UnitedHealth Group were worth $142,159,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Delta Financial Group Inc. increased its stake in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares in the last quarter. Signature Resources Capital Management LLC grew its stake in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the period. Saxony Capital Management LLC raised its stake in UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the period. GoalVest Advisory LLC boosted its position in shares of UnitedHealth Group by 0.6% in the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 18 shares during the period. Finally, Fiduciary Group LLC raised its position in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after purchasing an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. Barclays decreased their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday. Bank of America lowered their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Wells Fargo & Company lifted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Morgan Stanley cut their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.
UnitedHealth Group Price Performance
Shares of UNH stock opened at $615.01 on Wednesday. The company has a market cap of $565.98 billion, a P/E ratio of 40.07, a PEG ratio of 1.84 and a beta of 0.58. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock’s 50-day moving average is $582.95 and its 200 day moving average is $547.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.56 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.37%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- How to Calculate Inflation Rate
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Consumer Discretionary Stocks Explained
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
- 3 Small Caps With Big Return Potential
- Is Palantir’s AI Edge Enough to Justify Its Price?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.